22nd July 2019
A unique gateway to help firms scale up
Following an intensive selection process by a dedicated European-Canadian jury, 13 European companies were named as participants the 2019 edition of the EIT Health GoGlobal Canada programme, which will offer them a unique gateway to Canada.
GoGlobal Canada will enable the start-ups and SMEs to enter three recognised Canadian innovation hubs, which can act as major stepping stones into the North American market, while also initiating significant collaboration opportunities with qualified stakeholders.
During 2019, participants in the programme will be involved in:
- A preparatory workshop for Canada during the European medtech event MedFIT, took place during 25-26 June in Lille, France. It was an opportunity for companies to meet the local partners and have a first level of understanding of the local market opportunities.
- A ten-day immersion roadshow in the autumn in British Columbia, Ontario and/or Quebec provinces to meet the local players (support structures, KOLs and potential partners), gain first visibility and traction and understand the local innovation trends and healthcare market access opportunities.
- A final event and networking between the European and Canadian delegations during the MEDICA Fair in Düsseldorf, Germany, on 18-21 November, to enable companies to share their experiences and benefit from an international outreach.
The three EIT Health partners running the programme are among the leading healthtech clusters in Europe: Medicen Paris Region, a global competitiveness cluster that aims to position the Paris, France Region as a European industrial leader in diagnostic and therapeutic innovation and leading-edge health technologies; Medical Valley, an internationally leading cluster in the medical engineering sector based in Nuremberg, Germany; and Medicalps, a healthcare industry cluster (biotechnologies, medical devices, e-heath) in the heart of French Alps.
GoGlobal Canada participants for 2019
The following companies were selected for the programme:
AdEchoTech: An innovative French SME operating in the MedTech/Telemedicine sector. The company designs and manufactures remote robotic ultrasound systems capable of providing ultrasound diagnosis from a distance in real time, using internet or satellite connections.
Alreh Medical: Alreh Medical designs and manufactures rehabilitation equipment. It is specialised in physical and cognitive rehabilitation devices for elderly (activLife brand) and in rehabilitation equipment for paraplagic users (iStander , Activ+, Activ Drive brands).
evolucare: evolucare is a French family owned SME in healthcare IT. It has been successfully in business for 30 years in France and French-speaking countries of Africa. It has quite a large portfolio for a small company (ranging from EHR, Medical Imaging, Critical Care, Social Care to Analytics), and has invested intensively in innovation, in particular in AI.
HemCheck: HemCheck Sweden AB is a public (Nasdaq First North) medical technology company and is based on an invention by Dr Mathias Karlsson to allow POC detection of hemolysis in blood samples. HemCheck is manufacturing and marketing a CE-marked concept, Helge™, which detects hemolysis in blood samples in vacuum tubes and blood gas syringes during blood sampling at the point of care, with the aim to improve healthcare quality and patient flows while reducing costs.
Metafora: Metafora develops diagnostic tests that detect abnormalities in cellular metabolism. Using patented reagents that quantify cell nutrient transporters, coupled with powerful algorithms, the platform is able to detect abnormal nutrient consumption linked to illnesses such as neuro-metabolic diseases or cancer. Metafora already launched METAglut1 on the European market, a CE-marked test for a neuro-metabolic condition, GLUT1DS.
Milvue: Milvue is an innovative and reliable artificial intelligence medical device for real-time diagnostic assistance with emergency radiology, and more particularly, x-rays. Milvue automates the detection of x-ray-related abnormalities in an emergency workflow. The mission is to improve reliability and fasten diagnosis by reducing errors and time to diagnosis while improving communication between physicians.
Mindpax: Mindpax is an early stage digital medicine company that is building comprehensive digital therapy for severe psychiatric diseases using new biomarkers, digital phenotyping and long-term monitoring of patients.
myPatientSpace: myPatientSpace is a scalable eHealth platform enabling healthcare providers and life science companies to provide digital engagement for their patients. The solution is easily branded and rapidly configured for any pathway. myPatientSpace app is the patient’s treatment companion, bringing together education, consent, tasks, patient data and provider collaboration. The smart engine automates engagement and tasks across the patient’s pathway – supporting better outcomes, improving patient experience, gathering data, reducing costs and driving efficiency in care.
Rheonova: Rheonova has developed Rheomuco, an IVD medical device that uses lung mucuos rheology to evaluate lung congestion. Rheonova delivers a point-of-care test within 10 minutes for €10, with a quantitative biophysical marker and a specificity above 80%. It develops a series of test (diagnostic, prediction, companion) for chronic obstructive diseases like COPD, cystic fibrosis, severe asthma and bronchiectasis.
SanoLiBio: SanoLiBio focuses on the enrichment of rare cells taken from liquid biopsy, such as circulating tumor cells (CTCs). They have developed a fully automated enrichment platform to make CTCs available for early stage cancer diagnostic, next-generation sequencing and drug development.
Systserv: Systserv has developed DoctorsHello, an interactive “Connect-Collaborate-Share” ecosystem based on a network of collaborators (healthcare professionals/general users/healthcare businesses and policy decision makers), ensuring quality services. The ecosystem supports collaboration, provision of added-value services and easier reach to medical discovery, through rich data, research and education.
Tongue Lab: Tongue Lab develops the TRP, the first custom-made device for tongue functions and breathing re-education. Markets and uses include: Medical: cure of snoring, obstructive sleep apnea (OSA), prevention of comorbidities; Dental: orthodontics, bruxism; nasal breathing; Wellness: sports and work performance.
Worldish: Worldish helps healthcare professionals and patients overcome their language barriers through its digital communication tool Helen. Helen provides translation support and documentation support using global healthcare protocols and standards.
EIT Health rewards societal impact at Pitch Contest
Amparo takes 1st place at MedtecLIVE
EIT Health supported Optellum in AI world-first
Breakthrough in lung cancer detection technology
EIT Health-entrepreneur on Medicine’s Maker ‘Power List’
Evelina Vågesjö, CEO at Ilya Pharma